InvestorsHub Logo

boi568

08/23/20 11:27 AM

#266766 RE: JWC3 #266765

I am sure that the AD group from the PR are not paying anything. Sales will start with other patients, and only after application to the TGA. Don't expect any revenue until the next quarter is reported in 2021, and even then it won't be much.

TempePhil

08/23/20 5:24 PM

#266817 RE: JWC3 #266765

JWCn,agreed. Revenue this month is possible, as the HLP PR said for our Alz patients that have completed the trial. Then there are also the many other ALZ patients that may be requesting (as verified by Anavex and TGA).

The agreements may already be in place between Anavex and HLP. And it does not take long to overnight a few thousand pills to Australia. Next month (september) revenue is even more likely, and still "this quarter"!

Totally agree, the revenue will drive SP. Cant wait for Anavex to stop claiming to be "a clinical-stage biopharmaceutical company", and just be a
"biopharmaceutical company"!